Skip to main content
. 2022 Apr 11;12:814413. doi: 10.3389/fcimb.2022.814413

Table 4.

Comparison of the results of molecular and ELISPOT assays using clinical samples of clinically diagnosed new PB leprosy patients and healthy donor.

Method Gene or antigen (loci) Positive value p-value
PCR vs. nested PCR PCR Nested PCR PCR Nested PCR
FolP (Outer primers) FolP (Inner primers) 12 (12.2%) 80 (81.6%) 0.0001
RpoB (Outer primers) RpoB (Inner primers) 10 (10.2%) 84 (85.7%) 0.0001
GyrA (Outer primers) GyrA (Inner primers) 17 (17.3%) 91 (92.9%) 0.0001
At least one gene is positive At least one gene is positive 17 (17.3%) 91 (92.9%) 0.0001
PCR vs. ELISPOT PCR ELISPOT PCR ELISPOT
At least one gene is positive At least one antigen is positive 17 (17.3%) 90 (91.8%) 0.0001
Nested PCR vs. ELISPOT nested PCR ELISPOT nested PCR ELISPOT
At least one gene is positive At least one antigen is positive 91 (92.9%) 90 (91.8%) 1.0000